Abstract:Abstract: Objective To investigate the expression of suppressor of cytokine signaling3 (SOCS3) in laryngeal squamous cell carcinoma (LSCC), and to study the correlation between the expression of SOCS3 and signal transducer and activator of trans pSTAT3, and that between the expression of SOCS3 with clinicopathological factors of LSCC. Methods Immunohistochemical staining(SP method) was used for detecting the expression of SOCS3, pSTAT3 in 40 specimens of surgically resected LSCC and 11 of paracancerous normal laryngeal tissue. Results ① The expression of SOCS3 in LSCC was significantly lower than that in normal laryngeal tissue (P=0.000). The expression of pSTAT3 in normal laryngeal tissues was significantly lower than that in LSCC (P=0.000). ② Significant negative correlation was observed between the expression of SOCS3 and that of pSTAT3 (r=-0.459, P=0.003). ③ The expression of SOCS3 was significantly related with the pathologic grading and lymphatic metastasis, but not with the age, gender, and clinical stage of the patients. Conclusion The SOCS3 protein is omniexpressed in all normal laryngeal tissues, but less expressed in LSCC. The expression of SOCS3 is negatively correlated to that of pSTAT3, which suggests that SOCS3 plays an important role in inhibiting cell proliferation and promoting cell apoptosis in LSCC. The expression of SOCS3 protein is not related to patients’ age, gender, Tstage and tumor position, but related to cell differentiation level and lymphatic metastasis.